Table 1.
Aim | Design/method | Outcome measures/outputs | When collected |
1 | Controlled pre-post study involving retrospective review of medical records | Rates of potential DDIs Rates of clinically relevant DDIs Rates of patient harm |
Before and after EMM |
2 | Human factors evaluation—observations and interviews with prescribers | Alert usability and acceptability, barriers and facilitators to optimal use of alerts | After EMM |
3 | Analysis of alert data extracted from EMM systems | Alert burden (alerts/patient; alerts/order; alerts/prescriber) | After EMM |
4 | Analysis of patient and medication information collected during retrospective review and extracted from clinical information systems | Algorithms which predict clinically relevant DDIs | After EMM |
DDI, drug–drug interaction; EMM, electronic medication management.